The global liposome drug delivery market was valued at US$ 3.6 Bn in 2022 and is projected to expand at a considerable CAGR from 2022 to 2027.
The liposomal drug delivery device market comprises of sales of liposomal drug delivery devices and related services by entities like partnerships, organizations, sole traders who manufacture liposomal drug delivery devices. Liposomes are basically microscopic colloidal spheres that are used in delivering drug molecules to the site of action. Liposomal drug delivery devices are used in numerous patient care settings like clinics, diagnostic centers, home care settings, hospitals, and pharma companies.
New strategies in surface modification of liposomes are generating incremental opportunities for pharmaceutical companies. The liposome drug delivery is being highly publicized as a useful biocompatible tool for the vehiculation and delivery of lipophilic, hydrophilic, and amphiphilic compounds. However, high toxicity and resistance in high doses are some of the limitations faced by companies in the liposome drug delivery market. Hence, companies are transitioning from simple conventional vesicles to second-generation liposomes by attuning the lipid composition and surface with different ligands.
Croda International, Plc, a UK-based specialty chemicals company, acquired Avanti Polar Lipids, Inc. for $260 million. The acquisition is expected to expand life sciences products, cGMP production capabilities, and pharmaceutical services for biotechnology, life science, and expand customers for Croda International. Avanti Polar Lipids Inc. is a USA-based company that specializes in lipid-based drug delivery technology for next-generation pharmaceuticals.
Liposome Drug Delivery Market is segmented based on the type, applications, companies, and regions.
By Type, Liposome Drug Delivery Market has been segmented into
By Application, Liposome Drug Delivery Market has been segmented into,
The report offers an in-depth assessment of the growth and other aspects of the Liposome Drug Delivery Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.
North America dominated the global liposome drug delivery market in 2020 and the trend is expected to continue during the forecast period The liposome drug delivery market in the Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2026. The growth of the market in the region can be attributed to an increase in the number of patients suffering from chronic diseases and the focus of leading players on strengthening their presence in emerging markets.
Liposome Drug Delivery Market highlights the potential growth opportunities in upcoming years while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects in the global market. The Global Liposome Drug Delivery Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
The report incorporates an in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis, and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers, and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2021-2026. The report presents the analysis of the Liposome Drug Delivery Market for the historical period of 2017-2021 and the forecast period of 2021-2026.
Reports Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 3.6% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Gilead Sciences, Inc. (NasdaqGS :GILD), Pacira BioSciences, Inc. (NasdaqGS :PCRX), Sun Pharmaceutical, Johnson & Johnson, Luye Pharma |
Regions Covered | • North America • Europe • Asia-Pacific • Rest of the World |
Countries Covered | • US • Canada • Germany • France • UK • Italy • Spain • Rest of Europe • China • Japan • India • Australia • South Korea • Rest of Asia-Pacific • Middle East & Africa • Latin America |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 124 |
Customization Available | Yes, the report can be customized as per your needs |
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
What is the study period of this market?
The Liposome Drug Delivery Market is studied from 2017 - 2027.
Who are the key players in Liposome Drug Delivery Market?
Gilead Sciences, Inc. (NasdaqGS :GILD), Pacira BioSciences, Inc. (NasdaqGS :PCRX), Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang, and others.
What are the significant types of Liposome Drug Delivery Market?
Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others.
What are the major end-use applications of the Liposome Drug Delivery Market?
Fungal Infection Therapy, Cancer & Tumor Therapy, Others.
What segments are covered in the Liposome Drug Delivery Market report?
The Global Liposome Drug Delivery Market is Segmented on the basic of Product, Application, and Geography.
How can I get a sample report/company profile for the Liposome Drug Delivery Market?
The sample report for the Liposome Drug Delivery Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.